Stock listing
Solasia Pharma Kk
Selected listing: A2DN9S · LS · EUR · DE
Solasia Pharma Kk (Lang & Schwarz: A2DN9S), Health Technology. Latest release Aug 13, 2026: Consolidated Financial Results for the Six Months Ended June 30…
- Ticker
- Lang & Schwarz: A2DN9S
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- Lang & Schwarz
- Currency
- EUR
Latest news from Solasia Pharma Kk
Consolidated Financial Results for the Six Months Ended June 30, 2026 (Under IFRS)
August 13, 2026
Solasia Announces Launch of Darvias® in Japan
August 22, 2022
Solasia Pharma K K : Consolidated Financial Results for the First Six Months of the Fiscal Year Ending December 31, 2022 (under IFRS)
August 15, 2022
Solasia Pharma K K : Announces Topline Data from Phase III AGENT Study of SP-05(arfolitixorin)
August 3, 2022
Solasia Pharma K K : Announces Capital and Business Alliance with Nippon Kayaku Co., Ltd.
June 28, 2022
Research Solasia Pharma Kk
Alternate listings
4597:TSE
JP · JPY
Alternate listing for Solasia Pharma Kk; the primary context on this page is A2DN9S:LS.
A2DN9S:LSX
DE · EUR
Alternate listing for Solasia Pharma Kk; the primary context on this page is A2DN9S:LS.
9SO:FWB
DE · EUR
Alternate listing for Solasia Pharma Kk; the primary context on this page is A2DN9S:LS.
9SO:SWB
DE · EUR
Alternate listing for Solasia Pharma Kk; the primary context on this page is A2DN9S:LS.